Biomarkers in Alzheimer's disease clinical trials: 2025.
- DOI
- 10.1002/trc2.70217
- Published
- 2026 Jan-Mar
- Container
- Alzheimer's & dementia (New York, N. Y.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/trc2.70217,
title = {Biomarkers in Alzheimer's disease clinical trials: 2025.},
author = {Osse AML and Zhou Y and Kinney JW and Hooyman A and Sengupta A and Fonseca J and Burstein AH and Owen M and Nisenbaum L and Fillit HM and Cheng F and Cummings JL},
year = {2026},
journal = {Alzheimer's \& dementia (New York, N. Y.)},
doi = {10.1002/trc2.70217},
url = {https://doi.org/10.1002/trc2.70217}
}RIS
TY - JOUR TI - Biomarkers in Alzheimer's disease clinical trials: 2025. AU - Osse AML AU - Zhou Y AU - Kinney JW AU - Hooyman A AU - Sengupta A AU - Fonseca J AU - Burstein AH AU - Owen M AU - Nisenbaum L AU - Fillit HM AU - Cheng F AU - Cummings JL PY - 2026 JO - Alzheimer's & dementia (New York, N. Y.) DO - 10.1002/trc2.70217 UR - https://doi.org/10.1002/trc2.70217 ER -
APA
AML, O., Y, Z., JW, K., A, H., A, S., J, F., AH, B., M, O., L, N., HM, F., F, C., & JL, C. (2026). Biomarkers in Alzheimer's disease clinical trials: 2025.. Alzheimer's & dementia (New York, N. Y.). https://doi.org/10.1002/trc2.70217
Source records
- pubmed · retrieved 2026-09-26T19:04:04.723Z
- europe-pmc · retrieved 2026-09-26T19:04:04.734Z
- doaj · retrieved 2026-09-26T19:04:04.741Z